Mirloks - anti-inflammatory agent.  Mirloks 7 5 mg

Pharmacological action

The drug analgesic, anti-inflammatory and antipyretic activity.

The active substance Mirloksa - meloxicam.

Product form

Mirloks release tablets.

Indications Mirloksa

The drug is used for the symptomatic treatment of osteoarthritis, rheumatoid arthritis, ankylosing spondylitis (ankylosing spondylitis).

Instructions Mirloksa: how to use

Mirloks recommended to be taken with food once a day.

Osteoarthritis at the beginning of treatment prescribed 7, 5 mg per day. If such a daily dose will be ineffective, it increased to 15 mg.

When ankylosing spondylitis Mirloksa prescribed 15 mg per day. This is the maximum allowable dosage, so if it proves ineffective, it is recommended to change the medication.

In rheumatoid arthritis Mirloksa administered 15 mg per day. During treatment, considering the change of state of the patient, the daily dosage is reduced to 7, 5 mg.

For patients on hemodialysis or renal insufficiency, the maximum daily dose of the drug was 7, 5 mg.  Mirloks 15 mg

side effects

After applying Mirloksa may feel abdominal pain, flushing, dry mouth, may begin coughing, vomiting, nausea, diarrhea or constipation, dizziness, bleeding in the gastrointestinal tract, exacerbation of asthma, headache.

There are reviews of Mirlokse, which became the cause of hepatitis, renal failure, nephritis, kidney necrosis, tinnitus, tachycardia, conjunctivitis, esophagitis, erosions or ulcers in the gastrointestinal tract, edema, skin rashes, itching, increased photosensitivity of the skin, exudative erythema multiforme, leukopenia, thrombocytopenia, anemia, allergic vasculitis, fever.

Contraindications Mirloksa

Mirloks is contraindicated in severe renal or hepatic insufficiency, peptic ulcer gastrointestinal hypersensitivity to meloxicam, "aspirin" asthma, pregnancy, breastfeeding.

The pediatric formulation is used.

Under medical supervision is recommended to take the drug to elderly patients, those suffering from chronic heart failure, accompanied by circulatory disorders, as well as patients who were previously treated for gastrointestinal erosions or ulcers.

Patients taking Mirloks should abandon the treatment on driving the car, if the drug makes them drowsiness, headache, or dizziness.

The instructions Mirloksa indicated that the risk of erosion or ulceration in the gastrointestinal tract is increased in combination with the drug nesteroidami, including with aspirin.

In appointing the drug take into account that its active ingredient reduces the effectiveness of intrauterine contraceptive devices and means of lowering the pressure increases lithium toxicity and negative effects of methotrexate on the hematopoietic system.

Due to the combination with cyclosporine and Mirloksa diuretics often develop kidney failure.

Concomitant use Mirloksa warfarin, ticlopidine, heparin, fibrinolizinom can cause bleeding, so if you need to share the purpose of these drugs is recommended to continuously monitor the performance of blood clotting.